Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-29

Clinical Trial Update: An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab

View source ↗

Summary

This completed observational study evaluated quality of life in rheumatoid arthritis patients treated with rituximab, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2015-12-29